Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Problem Formulation
- 1.Does herbal medicine sambiloto affect the blood glucose levels of obese sufferers?
- 2.Does brisk walking affect blood glucose levels in obese sufferers?
- 3.Does the combination of bitter herbal medicine and brisk walking have an effect on blood glucose levels in obese sufferers?
- 4.Is there a difference in the effectiveness between herbal bitter and brisk walking and the combination on blood glucose levels in obese sufferers?
- 5.Knowing the effect of herbal medicine Sambiloto on blood glucose in obese sufferers.
- 6.Knowing the effect of brisk walking on blood glucose in obese sufferers.
- 7.To determine the effect of the combination of herbal medicine Sambiloto and brisk walking on blood glucose levels in obese sufferers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedStudy Start
First participant enrolled
September 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedSeptember 19, 2024
September 1, 2024
10 days
July 21, 2024
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Glucose Differences
Difference in blood glucose before and after treatment
7 consecutive day
Study Arms (5)
Brisk Walking
EXPERIMENTALModerate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
Herbal Medicine Sambiloto
EXPERIMENTALJamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Combination
EXPERIMENTALModerate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute. Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Control Obese
NO INTERVENTIONObese with no intervention
Control Normal
NO INTERVENTIONNormal with no intervention
Interventions
Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute. Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days
Eligibility Criteria
You may qualify if:
- Willing to be a respondent with informed consent
- Obesity sufferers in the Jekan Raya District area
- Have a BMI ≥ 25 kg/m2 (Obesity I)
- Adult age (19-39 years)
You may not qualify if:
- Not being present or out of town during the research
- Unable to continue research due to serious illness or death
- Withdraw while participating in the research
- Have a history of drug allergies
- Experiencing decreased consciousness
- Experiencing an extremity injury
- Have a history of cardiovascular disease, kidney disease or stomach ulcers
- Have a history of bloody stools
- Are pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes Veronica Agustin
Universitas Palangka Raya
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ketua Komite Etik
Study Record Dates
First Submitted
July 21, 2024
First Posted
July 25, 2024
Study Start
September 4, 2024
Primary Completion
September 14, 2024
Study Completion
October 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09